Track topics on Twitter Track topics that are important to you
2411 Stanwell Drive
United States of America
Phone: (925) 288-6000
Fax: (925) 288-6001
An expanded agreement between HHS' Biomedical Advanced Research and Development Authority and Cerus will provide an additiona -More-
Cerus Corporation (NASDAQ: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, is scheduled to present a corporate update at the...
Cerus Corp. (blood transfusion safety devices) netted $49.7mm through a public sale of 12.2mm common shares at $4.10. Proceeds will support ongoing development and commercialization of the Intercept p...
Cerus Corporation (Nasdaq: CERS) announced today that Dr. Laurence M. Corash, co-founder and chief scientific officer, and Lainie Corten, vice president of global marketing, are s...
Cerus Corp. (blood transfusion safety devices) netted $57.2mm through a public sale of 14mm common shares (including the overallotment) at $4.10. Proceeds will support ongoing development and commerci...
Cerus Corporation (Nasdaq:CERS) announced today that its first quarter results will be released on Tuesday, May 8, 2018, after the close of the stock market. The company will host...
Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and year end results for 2017 will be released on Thursday, March 8, 2018, after the close of the stock mar...
Cerus announced that Health Canada has approved the commercialization of Intercept blood system for platelets.
A series of 2-Cl-benzimidazole derivatives was synthesized and assessed for antibacterial activity. Antibacterial results indicated that compounds 2d, 2e, 3a, 3b, 3c, 4d and 4e showed promising activi...
A new series of heterocyclic molecules bearing sulfonamide linkage has been synthesized and screened for antibacterial activity. During antibacterial screening using broath dilution method, molecules ...
At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development o...
Condensed Consolidated Unaudited Balance Sheets
We have published hundreds of Cerus news stories on BioPortfolio along with dozens of Cerus Clinical Trials and PubMed Articles about Cerus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cerus Companies in our database. You can also find out about relevant Cerus Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells. In vertebrates, it is composed of blo...